Neladalkib produced a 31% ORR in 253 TKI-pretreated patients and a 46% ORR in lorlatinib-naive patients, supporting utility after multiple prior ALK inhibitors. Activity against the ALK G1202R ...
Locally advanced or metastatic urothelial carcinoma (la/mUC) is a highly aggressive malignancy with a poor prognosis. For decades, platinum-based chemotherapy has remained the cornerstone of ...
BERLIN, GERMANY, March 4, 2026 /EINPresswire.com/ — As organizations expand their use of Elasticsearch for analytics, observability, and operational data workloads ...
Search Guard discusses application-level Encryption at Rest for Elasticsearch, including Lucene files, snapshots, and translogs. BERLIN, GERMANY, March 4, 2026 ...